from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0534c/menA

LFCtreatmentdescriptionclass of inhibitor

-0.712

Amikacinug/mL Amikacintranslation

-1.723

Cap5-10ug/mL Capreomycintranslation

-1.756

Rox10-50 ug/mL Roxithromycintranslation

-0.050

SM2-5 ug/mL Streptomycintranslation

-2.087

Tet5-10 ug/mL Tetracyclinetranslation

0.278

Rif0.2-5ug/mL Rifampicintranscription

-0.377

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.045

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.332

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.426

CPZ10-50 ug/mL Chlorpromazinerespiration

0.228

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.852

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.082

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.461

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.369

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.121

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.807

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.594

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.162

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.018

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.533

KCN5-20 ug/mL Potassium cyaniderespiration

0.018

NaN30.2-2 mM Sodium aziderespiration

-0.501

Nigericin50 uM Nigericinrespiration

0.383

TRC10-150 ug/mL Triclosanrespiration

0.569

TRZ10-25 ug/mL Thioridazinerespiration

-2.403

Valinomycin0.5-10 uM Valinomycinrespiration

-0.552

ZnSO42 mM ZnSO4respiration

-0.410

menadione6-10 ug/mL Menadionerespiration

0.331

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.072

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.819

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.112

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.088

NRP_1Non-replicating persistence stage 1dosRassociated

0.285

Amp0.2mg/mL AmpicillincellWall

-0.138

Cephalexin20-100 ug/mL CephalexincellWall

-0.251

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.073

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.125

EMB10-20 ug/mL EthambutolcellWall

-0.325

Eta12-40 ug/mL EthionamidecellWall

-0.190

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.028

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.108

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.635

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.818

BZA0.12 mg/mL BenzamidearomaticAmides

0.958

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.628

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.487

H2O24 mM hydrogen peroxideDNAdamaging

-0.703

Levo10 ug/mL LevofloxacinDNAdamaging

0.603

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.080

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.126

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.363

UVUV-irradiationDNAdamaging

0.316

ARP41-4 ug/mL Antitubercular compound ARP4?

0.236

Antimycin12.5-50 ug/mL Antimycin A?

-0.501

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.004

PA_110-50 ug/mL Antitubercular compound PA-1?

1.017

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.900

PA8240.2-2 ug/mL PA-824?

0.344

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.865

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.008

Verapamil50 uM Verapamil?

-0.428

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.626

methoxatin10-20 ug/mL Methoxatin?